Navigation Links
New Combination Therapy Option for HIV Patients

A HIV protease inhibitor Aptivus ( tipranavir ) , has been recently approved by the Food and Drug Administration // . The capsules are to be given in combination with ritonavir for treatment of HIV-1 infected adults. This is the second drug approved for patients with advanced HIV disease, and provides a new therapy for patients with limited treatment options.

The benefits of Aptivus in combination with ritonavir, has shown to be an effective in treating patients who have tried many HIV medicines but found no success. Taking 200 mg of ritonavir twice daily was shown to boost the level of Aptivus, and lowered the amount of virus in the blood compared to the currently available anti-HIV medicines. However like all drugs it is also known to cause serious liver problems especially in patients with liver disease. Some of the adverse events seen in clinical trials include skin rashes and raised cholesterol and triglycerides levels.

Specialists also say that patients using Aptivus with low-dose ritonavir should report the use of any concomitant medication due to the possibility of potential drug interactions. Some of the drugs that can cause problems when used together with Aptivus include antiarrhythmics , antihistamines, ergot derivatives , medicines that speed up the digestive tract, herbal products and also medicines that lower cholesterol levels, and medicines to treat mental problems.

Companies Manufacturing and marketing the drugs say they intend to do post marketing studies on the drug to look at drug-drug interactions and see how Aptivus works in other groups of people, such as patients taking HIV medicines for the first time, children, and HIV-1 positive women.
'"/>




Page: 1

Related medicine news :

1. Consensus on "Combination Therapy" for Breast Cancer
2. Drug Combinations May Boost Stroke Risk
3. Combination therapy to treat breast cancer
4. Combination regime may work against prostate cancer
5. Smoking and Breast Cancer - A Deadly Combination
6. New Drug Combination Found To Improve Memory in Alzheimer’s Patient
7. A Combination Of Drugs Effective In The Treatment Of Hormone-Refractory Prostate Cancer
8. Combination Therapy Effective In Improving Lung Cancer Survival
9. Combination Therapy Found To Improves Stroke Recovery
10. Combination Therapy Found To Be More Effective In Treating Brain Cancer
11. Combination of Clopidogrel-aspirin is better for preventing stroke than only aspirin
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/24/2017)... OH (PRWEB) , ... July 24, 2017 , ... ... place August 13-17 in National Harbor, MD. This year's theme focuses on the ... the principal benchmarks for quality and integrity in testing and calibration will be ...
(Date:7/24/2017)... (PRWEB) , ... July 24, 2017 , ... A Southern ... food addiction to sexual abuse, and how she has overcome them. “Forbidden Memories: A ... in her life and how she has risen above. , In “Memories,” readers get ...
(Date:7/24/2017)... Church, VA (PRWEB) , ... July 24, 2017 ... ... and Managers, **Presented by FDAnews and MSceppa Consulting **, Aug. 22-23, 2017 – ... ends on Friday, July 28. , Increased FDA scrutiny and growing demands to ...
(Date:7/24/2017)... ... ... customizable and interactive Bible study guide for children. “The Perfect Gift” is the creation of ... accepted Christ as her Savior, yet never studied His word, surrendered to His will, or ... book to her children, so they would know the importance of the truth. She ...
(Date:7/24/2017)... ... 24, 2017 , ... The Center for Addiction Recovery Training ... host a second Multiple Pathways of Recovery Conference on October 23-26, 2017. This ... from CCAR’s foundational principle – a belief in multiple pathways of recovery, aims ...
Breaking Medicine News(10 mins):
(Date:7/20/2017)... July 20, 2017  Prime Therapeutics LLC (Prime) released this ... M.D., following today,s Institute for Clinical and Economic Review,s (ICER) ... the effectiveness and value of abuse-deterrent formulations (ADF) of opioids. ... roundtable at the meeting. ... cost benefit to the use of abuse-deterrent formulations (ADF) in ...
(Date:7/14/2017)... 2017 It should come as no surprise to ... in the midst of a crippling opioid epidemic. According to ... number of overdose deaths from opiate-based medications has quadrupled, Says, ... million dead from 2001 to 2015". During this time, the ... similarly quadrupled, drawing a compelling link between prescription and eventual ...
(Date:7/12/2017)... INDIANAPOLIS , July 12, 2017  Eli Lilly and ... settlement agreement with generic companies to resolve pending patent litigation ... Virginia regarding the Cialis ® ... expire on April 26, 2020. As part of the agreement, ... on September 27, 2018. "The unit dose patent ...
Breaking Medicine Technology: